返回 Agenda
Session 5: Analysis Plan (continued)
Session Chair(s)
Rafe Donahue, PhD
Senior Director, Biometrics
Sierra Oncology, United States
Important statistical considerations for constructing an analysis plan for a clinical trial will be discussed.
- Treatment allocation
- Analysis groups – intent to treat or correct protocol
- Common statistical methodology
- Multiple endpoints and multiple comparisons
- Interim analysis
- Subgroup analysis
- Examples